Ardelyx wins long battle for FDA approval of kidney-disease treatment

Ardelyx Inc. ARDX, on Tuesday won its long fight for U.S. regulatory approval of a treatment designed to help patients with chronic kidney disease. The biopharma company said late Tuesday that the U.S. Food and Drug Administration approved tenapanor, marketed under the brand name Xphozah, for…#ardelyxincardx #ardelyx #fda #xphozah #mikeraab #atictac
Source: Reuters: Health - Category: Consumer Health News Source Type: news